Does FUROSEMIDE Cause Second primary malignancy? 9 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Second primary malignancy have been filed in association with FUROSEMIDE (Furosemide). This represents 0.0% of all adverse event reports for FUROSEMIDE.
9
Reports of Second primary malignancy with FUROSEMIDE
0.0%
of all FUROSEMIDE reports
1
Deaths
8
Hospitalizations
How Dangerous Is Second primary malignancy From FUROSEMIDE?
Of the 9 reports, 1 (11.1%) resulted in death, 8 (88.9%) required hospitalization.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FUROSEMIDE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does FUROSEMIDE Cause?
Acute kidney injury (7,984)
Hypotension (4,468)
Dyspnoea (3,559)
Fall (3,410)
Drug ineffective (3,297)
Hyponatraemia (3,127)
Hypokalaemia (2,503)
Dehydration (2,195)
Off label use (2,147)
Fatigue (2,107)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which FUROSEMIDE Alternatives Have Lower Second primary malignancy Risk?
FUROSEMIDE vs FUROSEMIDE\SPIRONOLACTONE
FUROSEMIDE vs FUSIDATE
FUROSEMIDE vs FUSIDIC ACID
FUROSEMIDE vs FUTIBATINIB
FUROSEMIDE vs GABAPENTIN